Transanal Total Mesorectal Excision, commonly referred to as TaTME, is a colorectal workflow where access, exposure, insufflation, retraction, and closure support must work together as a system. For procurement teams and distributors, the key question is not simply “which transanal port should we buy?” A more useful question is: which access configuration, documentation package, and model scope should be evaluated for the hospital’s TaTME program?
This article reframes TaTME procurement as a product-architecture and documentation problem. It explains the major device components, the questions buyers should ask before quotation, and how AeroMed Surgical discusses TaTME access configurations in a conservative, IFU-led way.
Why TaTME procurement is usually a multi-component decision
A TaTME access setup may involve several product families. Depending on the hospital’s workflow, a procurement package can include a transanal single-port access platform, a wound retractor or protective sleeve, a ring retractor and hook configuration for exposure, and a closure support device. Each component may have its own model number, IFU, label, packaging, lot-traceability requirement, and regulatory document scope.
When these components are sourced or evaluated separately, the purchasing conversation can become fragmented. The buyer may receive a port quotation without exposure components, or a retractor quotation without understanding how it fits with the access platform. For a distributor, that creates avoidable follow-up work and increases the risk of quoting an incomplete package.
For TaTME access procurement, the practical question is not “one device or many devices.” The practical question is whether the selected components are documented, compatible, and quotable as a clear configuration.
The functional components to define before quotation
A distributor-facing TaTME discussion should normally define four areas before price is discussed:
- Access platform: the transanal single-port platform or sealed access configuration used for the working channel.
- Wound retractor / access sleeve: the sleeve or retractor component that supports access and physical separation according to the product design.
- Exposure support: ring and hook configurations, where required, for surface-level retraction or field exposure.
- Closure support: trocar-site or wound-closure support devices used according to IFU and hospital protocol.
These categories should be explained as functions, not as universal requirements for every case. Exact product use depends on current IFU, hospital protocol, surgeon preference, and local regulatory approval.
AeroMed product families relevant to TaTME discussion
AeroMed Surgical product architecture allows a distributor to discuss TaTME access as part of the broader Single-Port Access System and General / MIS portfolio. The table below is a public-facing orientation, not a final IFU or certificate matrix.
| Function | AeroMed product family | Procurement role | What to verify |
|---|---|---|---|
| Transanal access | HK-FDDC-4NOS · TaTME / transanal access configuration | Provides the sealed access platform for selected transanal single-port workflows. | Exact model, sleeve / retractor pairing, IFU, packaging, and CE documentation scope. |
| Exposure support | HK-QK ring family | Ring-retractor frame for selected exposure configurations. | Ring size, kit configuration, IFU, label, and compatibility with the intended workflow. |
| Tissue retraction | HK-LG hook family | Sharp or blunt hook options for tissue-specific retraction where appropriate. | Hook type, hook count, tissue condition, IFU language, and surgeon preference. |
| Closure support | HK-WHQ fascial closure device | Trocar-site fascial closure support with grasper-jaw retrieval logic. | Gauge variant, length, IFU, label, packaging, and market registration scope. |
Do not describe any TaTME bundle as a universal replacement, first-of-its-kind global solution, or clinically equivalent substitute unless the exact claim is supported by current documentation. Safe wording is: configuration-led access and exposure discussion according to current catalog, IFU, and model scope.
What changes when procurement is configuration-led
Configuration-led procurement does not claim that the surgeon’s clinical technique changes. It changes the distributor conversation and the hospital purchasing workflow. Instead of asking for isolated device prices, the buyer can request a complete product discussion covering access platform, sleeve / retractor compatibility, ring and hook options, closure support, documentation, sample availability, and quotation terms.
This approach is especially useful for distributors entering a new market. A clear configuration package helps them prepare a hospital evaluation conversation, identify which documents will be needed for registration, and avoid sending a partial quotation that later requires correction.
Questions a distributor should ask before quoting TaTME access
Before preparing a TaTME quotation, a distributor should collect the following information:
- Target country and registration pathway: Is the request for distributor due diligence, registration, hospital evaluation, or direct quotation?
- Product configuration: Is the buyer asking for access platform only, exposure support only, or a broader access package?
- Model and size needs: Has the surgeon or hospital identified a preferred access configuration or ring / hook setup?
- Documentation need: Does the buyer need catalog, IFU, label, CE documentation, packaging, or model matrix?
- Sample plan: Will the hospital evaluate samples before volume ordering? How many units and which models?
- Commercial terms: Quantity, shipping destination, incoterms, lead time, and quotation validity.
Regulatory and documentation logic
Public web pages should not compress multiple product families into a single broad regulatory statement. A TaTME access package may include several product families, and each family can have its own model scope, IFU, label, and certificate coverage. For this reason, AeroMed’s preferred public wording is “CE documentation available according to current certificate and model scope.”
For qualified distributors, the appropriate next step is to request the current documentation package for the exact configuration being evaluated. This may include catalog pages, model matrix, IFU, label, product photos, packaging information, CE documentation, and quotation support.
How this connects to AeroMed’s Single-Port Access System
TaTME is one application within the broader Single-Port Access System portfolio. AeroMed’s access-system logic should be understood as the combination of a wound retractor / protective sleeve and a selected sealed platform or cap. That same architecture supports multiple access workflows, including vNOTES, TaTME, selected hand-assisted configurations, robotic-platform configurations, and standard single-port access, depending on model scope and IFU.
For a distributor, this is commercially important. A TaTME discussion can open the door to broader access-system conversations with the same hospital: wound retractor, specimen retrieval bag, fascial closure, ring retractor, hand-assisted access, and robotic single-port access may be relevant to adjacent departments.
What to request from AeroMed Surgical
If you are evaluating AeroMed for TaTME access or colorectal access workflows, request the following as a package:
- TaTME / transanal access product brief.
- HK-FDDC-4NOS model information and compatible accessory notes.
- HK-QK ring and HK-LG hook matrix where relevant.
- HK-WHQ fascial closure model matrix if closure support is part of the inquiry.
- Current IFU, labeling, and CE documentation according to model scope.
- Product photos and packaging information for distributor or hospital review.
- Sample and quotation terms based on target country, quantity, and intended evaluation plan.
The strongest procurement discussion is not built around a dramatic price comparison. It is built around a complete, accurate, and document-supported configuration that a distributor can explain clearly to surgeons, procurement teams, and registration stakeholders.